Patni Rajiv 4
4 · BioXcel Therapeutics, Inc. · Filed Jan 16, 2025
Insider Transaction Report
Form 4
Patni Rajiv
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-15+44,000→ 44,000 totalExercise: $0.35Exp: 2035-01-15→ Common Stock (44,000 underlying)
Footnotes (1)
- [F1]On January 15, 2025, the Reporting Person was granted an option to purchase 44,000 shares of common stock, which vests in three equal installments on the first three anniversaries of the grant date, subject to his continued service as a Director through the vesting period.